Kelly Denner

Kelly Denner is Group Product Manager in the Transcatheter Mitral and Tricuspid Therapies unit at Edwards Lifesciences. Kelly is responsible for driving commercialization activities for innovative interventional cardiology devices in the US market. Prior to making the pivot to med tech and joining Edwards in 2018, Kelly worked as an HR Business Partner in the financial services industry. Kelly holds a BA in International Relations from Stanford University and an MBA from University of Virginia Darden School of Business.